RAMBALDI ALESSANDRO

Buracchi, C., Belotti, D., Moretti, A., Calabretta, L., Risca, G., Capelli, C., et al. (2023). Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry. Intervento presentato a: ESLHO Symposium, Salamanca, Spain. Dettaglio

Sauta, E., Robin, M., Bersanelli, M., Travaglino, E., Meggendorfer, M., Zhao, L., et al. (2023). Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. JOURNAL OF CLINICAL ONCOLOGY, 41(15 (May 20, 2023)), 2827-2842 [10.1200/JCO.22.01784]. Dettaglio

Maggioni, G., Bersanelli, M., Travaglino, E., Alfonso Piérola, A., Kasprzak, A., Sangerman Montserrat, A., et al. (2023). A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study. THE LANCET. HAEMATOLOGY, 10(2 (February 2023)), 117-128 [10.1016/S2352-3026(22)00323-4]. Dettaglio

Novelli, L., Raimondi, F., Carioli, G., Carobbio, A., Pappacena, S., Biza, R., et al. (2023). One-year mortality in COVID-19 is associated with patients’ comorbidities rather than pneumonia severity. RESPIRATORY MEDICINE AND RESEARCH, 83(June 2023) [10.1016/j.resmer.2022.100976]. Dettaglio

Venditti, A., Piciocchi, A., Soddu, S., Frigeni, M., Palmieri, R., Borlenghi, E., et al. (2023). Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial. In 65th ASH Annual Meeting and Exposition - December 9-12, 2023 (pp.1514-1514). AMER SOC HEMATOLOGY [10.1182/blood-2023-178505]. Dettaglio